<code id='4460485240'></code><style id='4460485240'></style>
    • <acronym id='4460485240'></acronym>
      <center id='4460485240'><center id='4460485240'><tfoot id='4460485240'></tfoot></center><abbr id='4460485240'><dir id='4460485240'><tfoot id='4460485240'></tfoot><noframes id='4460485240'>

    • <optgroup id='4460485240'><strike id='4460485240'><sup id='4460485240'></sup></strike><code id='4460485240'></code></optgroup>
        1. <b id='4460485240'><label id='4460485240'><select id='4460485240'><dt id='4460485240'><span id='4460485240'></span></dt></select></label></b><u id='4460485240'></u>
          <i id='4460485240'><strike id='4460485240'><tt id='4460485240'><pre id='4460485240'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:comprehensive    Page View:88
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In